Trials / Unknown
UnknownNCT04680858
Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19
Impact of Digital Enhanced Telecommunication for Team Communication in Endoscopic Procedures During COVID-19 Pandemic
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- University of Ulm · Academic / Other
- Sex
- All
- Age
- 18 Years – 68 Years
- Healthy volunteers
- Not accepted
Summary
Team work is highly challenged by the COVID-19 pandemic. Necessary protective equipment as FFP-mask and face shields impair communication significantly.Objective of the study is to evalaute the impact of digital enhanced telecommunication in endoscopic procedures.
Detailed description
Optimal communication is crucial for team work in high class endoscopy. Team work is highly challenged by the COVID-19 pandemic. Necessary protective equipment as FFP-mask and face shields impair communication significantly. Digital enhanced approaches to maintain team communication during endoscopic procedures are mandatory not only in actual circumstances. Materials and methods:A prospective, two-armed interventional study will be performed at an endoscopy unit at a tertiary center. 200 endoscopic examinations (EGD, colonoscopy, EUS, ERCP) were randomly assigned (1:1) to a group that was performed with DECT equipped endoscopy team or with standard communication. All examinations were performed under protective equipment. Primary outcome was rate of communication associated adverse events. Secondary outcomes included team subjectively perceived comfort with DECT enhanced communication during endoscopic work, duration of examinations, SAE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | DECT | Use of a digital enhanced telecommunication headset for team communication |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-01-31
- Completion
- 2021-02-15
- First posted
- 2020-12-23
- Last updated
- 2020-12-31
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04680858. Inclusion in this directory is not an endorsement.